SEROPREVALENCE OF HUMAN T-CELL LEUKAEMIA LYMPHOMA VIRUS TYPE-I (HTLV-I) IN PREGNANT-WOMEN, PATIENTS ATTENDING VENEREOLOGICAL OUTPATIENT SERVICES AND INTRAVENOUS-DRUG-USERS FROM SLOVENIA/
M. Poljak et al., SEROPREVALENCE OF HUMAN T-CELL LEUKAEMIA LYMPHOMA VIRUS TYPE-I (HTLV-I) IN PREGNANT-WOMEN, PATIENTS ATTENDING VENEREOLOGICAL OUTPATIENT SERVICES AND INTRAVENOUS-DRUG-USERS FROM SLOVENIA/, Folia biologica, 44(1), 1998, pp. 23-25
To establish current seroprevalence of human T cell leukaemia/lymphoma
virus type I (HTLV-I) infection in some low-and high-risk populations
from Slovenia, 10,369 and 869 serum samples collected during Slovenia
n 1994 unlinked surveys of human immunodeficiency viruses seroprevalen
ce in pregnant women and patients attending venereological outpatient
services, respectively, and 219 serum samples collected from Slovenian
intravenous drug abusers during 1995 and 1996, were screened for the
presence of anti-HTLV-I antibodies using commercial particle agglutina
tion test Serodia HTLV-I (Fujirebio, Tokyo, Japan), Only one sample ob
tained from a pregnant woman was found repeatedly positive in the scre
ening test, Presence of anti-HTLV-I antibodies in the reactive sample
was undoubtedly confirmed with supplemental Western blot test, The pre
valence of antibodies to HTLV-I in the Slovenian population might be s
omewhere between one in 10,000 (0.01%) and one in 15,000 (0.0066%), wh
ich is similar or even higher to prevalence rates in other European co
untries.